Recherche
-
Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase((R)))
(Antibiotics. vol. 12, n° 5, 2023-04-25)Article de revueLibre accès -
Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBase
(Pharmaceuticals (Basel). vol. 16, n° 10, pp. 1420, 2023-10-05)Article de revueLibre accès -
Adverse Drug Reaction-Related to Drug Shortage: A Retrospective Study on the French National Pharmacovigilance Database
(British Journal of Clinical Pharmacology. vol. 89, n° 3, pp. 1080-1088, 2023-03)Article de revueLibre accès -
Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysis.
(Frontiers in Pharmacology. vol. 14, pp. 1129244, 2023-05-15)Article de revueLibre accès -
Analgesic switching in chronic users of dextropropoxyphene in France
(Fundamental & Clinical Pharmacology, 2023-10-21)Article de revueLibre accès -
Second-degree burn induced by high-concentration topical capsaicin with mobility sequelae: a case report
(Pain Practice. vol. 23, n° 2, pp. 216-219, 2023-02)Article de revueLibre accès -
Real-World Treatment Patterns and Effectiveness of Patients With Advanced Renal Cell Carcinoma: A Nationwide Observational Study
(Clinical Genitourinary Cancer. vol. 22, n° 2, pp. 295-304, 2023-11-24)Article de revueLibre accès -
Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study
(Drug Safety. vol. 46, n° 9, pp. 857-866, 2023-09-01)Article de revueLibre accès -
Statin treatment is not associated with an increased risk of adrenal insufficiency in real-world setting
(Frontiers in Endocrinology. vol. 14, pp. 1254221, 2023-09-25)Article de revueLibre accès